Edgewise Therapeutics' rising cash burn signals concern. Sha...
Edgewise Therapeutics' rising cash burn signals concern. Shareholders could experience costly dilution if the company sells shares to fund another year's growth. It's advised for shareholders to keep a close eye on the company's cash burn.
We're Not Very Worried About Edgewise Therapeutics' (NASDAQ:EWTX) Cash Burn Rate
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment